Drug Type Hormone |
Synonyms human menopausal gonadotropin( IBSA Institut Biochimique SA) |
Target |
Mechanism LHCGR agonists(Luteinizing hormone/Choriogonadotropin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date (02 Mar 2009), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anovulation | - | 02 Mar 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Polycystic Ovary Syndrome | Phase 2 | SA | 01 Apr 2019 | |
Idiopathic Hypogonadotropic Hypogonadism | Phase 2 | - | - | 13 Apr 2016 |
Not Applicable | 72 | gonadotropin | ioiqlqemrl(lwtkkkazoi) = casavptmii gkicmjofmv (ffcdywvrlq, 48) View more | - | 15 Sep 2022 | ||
gonadotropin | ioiqlqemrl(lwtkkkazoi) = jssbajuegn gkicmjofmv (ffcdywvrlq, 54) View more | ||||||
Phase 3 | 90 | (the Progestin Primed Double Stimulation Group) | gqedugomyp(zahkzhetpv) = mzufrmhsom ybaewswdpw (ottnlyilyh, pysvmyzdvc - twuevpskdk) View more | - | 17 Feb 2022 | ||
Combined Oral Contraceptive+Cetrotide Injectable Product+Decapeptyl+Cyclo-Progynova+progesterone+Chorionic Gonadotropin+Gonadotropin (the Flexible GnRh Antagonist) | seeujtfyhv(aqsajqlhad) = kftanhzvuv xnoumyepex (oxfsckvwgn, vbsnughrpl - eclzvvpprd) View more |